Key Record Dates
ClinicalTrials.gov Identifier: | NCT02367781 |
---|---|
Brief Title: | A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) |
First Submitted : | February 13, 2015 |
First Submitted that Met QC Criteria : | February 13, 2015 |
First Posted : | February 20, 2015 (Estimate) |
Results First Submitted : | March 13, 2019 |
Results First Submitted that Met QC Criteria : | March 13, 2019 |
Results First Posted : | April 3, 2019 |
Last Update Submitted that Met QC Criteria : | July 15, 2021 |
Last Update Posted : | August 9, 2021 |